Targeting the activin receptor 1C on CD4+ T cells for cancer immunotherapy

Volume 13, Issue 1, December 2024 .

Source: OncoImmunology - January 8, 2024 Category: Cancer & Oncology Authors: Ying ZhengAndriana LebidLiam ChungJuan FuXiaoxu WangAndrea OtrocolJelani C. ZarifHong YuNicolas J. LlosaDrew M. Pardolla Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USAb Department of On Source Type: research